Very early researchEnded earlyNCT04630886What this trial is testingUse of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic SurgeryWho this might be right forSkin Neoplasms Riley McLean 34
Early research (Phase 1)Looking for participantsNCT07027488What this trial is testingAB821 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Melanoma and Normal or ImpairedAdvanced Melanoma Yale University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05372354What this trial is testingEvaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 260
Not applicableUnknownNCT03228095What this trial is testingVolatiles in Breath and Headspace Analysis - Diagnostic MarkersWho this might be right forTuberculosisGastric CancerPeptic Ulcer+13 more University of Latvia 3,000
Early research (Phase 1)Looking for participantsNCT07535112What this trial is testingLearn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D MutationWho this might be right forAdvanced/Metastatic Colorectal Adenocarcinoma Bayer 130
Testing effectiveness (Phase 2)Looking for participantsNCT06703177What this trial is testingSHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid TumorsWho this might be right forAdvanced Solid Tumors Suzhou Suncadia Biopharmaceuticals Co., Ltd. 876
Testing effectiveness (Phase 2)WithdrawnNCT05561491What this trial is testingONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma PatientsWho this might be right forMelanoma Targovax Oy
Early research (Phase 1)Temporarily pausedNCT06888323What this trial is testingTesting an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other TreatmentWho this might be right forRefractory Myelodysplastic Syndrome National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT05325866What this trial is testingA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionWho this might be right forSolid Tumors Amgen 260
Early research (Phase 1)Study completedNCT04551950What this trial is testingBintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)Who this might be right forCervical Cancer EMD Serono Research & Development Institute, Inc. 25
Not applicableStudy completedNCT02594696What this trial is testingProactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessWho this might be right forMajor DepressionSchizophreniaBipolar Disorder+5 more Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00002673What this trial is testingImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 30
Not applicableUnknownNCT05602337What this trial is testingA Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin CancerWho this might be right forMelanoma and Other Malignant Neoplasms of Skin DermTech 180
Early research (Phase 1)Study completedNCT06345001What this trial is testingA First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid CancersWho this might be right forHepatocellular Carcinoma (HCC)Solid Tumors Bayer 14
Testing effectiveness (Phase 2)Ended earlyNCT00642941What this trial is testingR1507 in Participants With Recurrent or Refractory SarcomaWho this might be right forSarcoma Hoffmann-La Roche 317
Early research (Phase 1)Ended earlyNCT02784795What this trial is testingLY3039478 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerColon Cancer+2 more Eli Lilly and Company 94
Early research (Phase 1)Study completedNCT03132792What this trial is testingAFPᶜ³³²T in Advanced HCCWho this might be right forHepatocellular CancerAFP Expressing Tumors Adaptimmune 39
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Testing effectiveness (Phase 2)Study completedNCT02272998What this trial is testingPonatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.Who this might be right forMalignant Neoplasm Sameek Roychowdhury 22
Not applicableStudy completedNCT01322165What this trial is testingNational Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular ConditionsWho this might be right forMarfan SyndromeTurner SyndromeEhlers-Danlos Syndrome+9 more National Heart, Lung, and Blood Institute (NHLBI) 3,706